Patents/Assignees

BEIJING INSTITUTE FOR CANCER RESEARCH

1 patent in portfolio

US12018335utility2024
Method for Quantitatively Detecting Deletion of Human CDKN2A Gene Copy, Primers and Use Thereof
0 cites